Addition of Isatuximab to RVd As Induction Therapy for Newly-Diagnosed, Transplant-Eligible MM Pts International Myeloma Foundation 4:24 3 years ago 221 Далее Скачать
DARA+RVd in Pts w/Transplant Eligible Newly Diagnosed Multiple Myeloma after 24 Months Maintenance International Myeloma Foundation 17:02 3 years ago 1 220 Далее Скачать
Isatuximab, Lenalidomide, Bortezomib, and Dex for Newly-Diagnosed Multiple Myeloma: GMMG-HD7 International Myeloma Foundation 10:37 6 months ago 565 Далее Скачать
Adding Isatuximab to Standard RVD May Improve Outcomes for Myeloma Patients | Elias Mai, MD | #ASH24 HealthTree Foundation for Multiple Myeloma 7:04 11 days ago 331 Далее Скачать
IMROZ- IsaRVd vs RVd in Newly Diagnosed Transplant Ineligible MM | Thierry Facon, MD | EHA 2024 HealthTree Foundation for Multiple Myeloma 5:06 6 months ago 163 Далее Скачать
The addition of isatuximab to KRd improves transplant outcomes for patients with multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:16 11 months ago 150 Далее Скачать
Isatuximab, lenalidomide, bortezomib and dexamethasone as induction therapy for NDMM patients ecancer 4:29 2 years ago 58 Далее Скачать
Isatuximab with VRd in Pts with Newly Diagnosed Multiple Myeloma Non-Eligible for Transplant International Myeloma Foundation 3:52 6 years ago 112 Далее Скачать
Episode 2 - Integrating Quadruplet Regimens in Newly Diagnosed Multiple Myeloma: Patient Focused ... Practice Point Communications 45:06 5 months ago 38 Далее Скачать
Isatuximab shows benefit in transplant-ineligible patients with newly diagnosed multiple myeloma ecancer 4:34 6 months ago 26 Далее Скачать
Phase III trial of RVd induction with or without isatuximab in newly diagnosed myeloma VJHemOnc – Video Journal of Hematology & HemOnc 6:37 3 years ago 68 Далее Скачать
Newly Diagnosed MM: Latest in Transplant Eligible Setting Multiple Myeloma Today 5:31 3 years ago 18 Далее Скачать
GRIFFIN updates: D-RVd vs RVd in transplant-eligible patients with newly diagnosed multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 2:13 2 years ago 158 Далее Скачать
Overall Survival Results in Transplant-Ineligible Newly Diagnosed MM pts: Phase 3 MAIA Study International Myeloma Foundation 15:30 3 years ago 872 Далее Скачать
An update on the RADAR trial: RCyBorD as induction therapy in newly diagnosed multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 1:46 2 years ago 281 Далее Скачать
Isatuximab, Carfilzomib, Lenalidomide, and Dex (Isa-KRd) in Pts with High-Risk Newly Diagnosed MM International Myeloma Foundation 11:13 2 years ago 558 Далее Скачать
The safety and efficacy of isatuximab, bortezomib, lenalidomide, and dexamethasone in NDMM VJHemOnc – Video Journal of Hematology & HemOnc 0:50 2 years ago 202 Далее Скачать
Rationale for Adding Daratumumab to RVd in Multiple Myeloma Targeted Oncology 1:16 6 years ago 156 Далее Скачать
Discussing Treatment Algorithm for Newly Diagnosed Multiple Myeloma with Dr. Caitlin Costello OncBrothers: Practice-Changing Cancer Discussions 22:28 7 months ago 2 042 Далее Скачать
Debate: Optimal Induction Therapy for Newly Diagnosed Transplant Eligible Myeloma - Triplets HMP Education 13:37 9 years ago 56 Далее Скачать
